Supreme Court preserves access to abortion pill by mail
The ruling maintains access to mifepristone while litigation continues. The drug can still be prescribed at pharmacies or by mail without requiring in-person visits.
CMS launches initiative to speed electronic prior authorization adoption
The effort, part of the agency’s ambitious Health Tech Ecosystem, aims to accelerate the industry’s progress before requirements on electronic prior authorization go into effect next year.
Labcorp expands Epic pact to make full test menu available
The Labcorp agreement continues the expansion of Aura, which gives healthcare providers access to tests from companies including Quest Diagnostics.
Oracle adds Cleveland Clinic CEO to board of directors
Dr. Tomislav Mihaljevic’s appointment comes months after Oracle named former Quest Diagnostics CEO Stephen Rusckowski to the board as the technology giant expands its reach in the healthcare sector.
Physicians skeptical of insurer pledges to reform prior authorization: survey
Only 33% of physicians surveyed by the American Medical Association said they believed voluntary pledges made by major insurers last year to reform prior authorization would result in any meaningful difference to the industry.
CMS suspends new Medicare enrollment of hospice, home health providers
The agency is halting enrollments for six months as part of the Trump administration’s broader attempt to crack down on fraud in government healthcare programs. Hospice and home health groups said they largely supported the moratorium.
Bayesian Health gets FDA nod for AI sepsis detection tool
Created by Johns Hopkins University researchers, the early warning system for sepsis aims to help physicians detect the serious condition earlier.
Mayo Clinic CEO to step down at year’s end
Dr. Gianrico Farrugia has led the system since 2019. The Rochester, Minnesota-based health system said it could elect Mayo’s next leader in November.
Employers say they prefer rebate-free PBM models
More than 90% of employers agreed a rebate-free approach is easier to understand and would improve drug price transparency, according to the survey conducted for Evernorth, which operates a pharmacy benefit manager.
FDA chief Marty Makary resigns from agency, ending tumultuous tenure
Makary’s exit ends a turbulent run marred by leadership upheaval, mass layoffs, political pressure and public spats with drugmakers.